Identifying early signs of Alzheimer's disease using language skills
Preclinical markers of Alzheimer's disease using psycholinguistic semantic measures
This study is looking at how people use language when naming animals to find early signs of Alzheimer's disease, helping to spot potential issues before symptoms appear, and making it easier for everyone to get checked.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11089729 on NIH RePORTER |
What this research studies
This research focuses on detecting early indicators of Alzheimer's disease (AD) by analyzing language use in cognitive tests. It aims to develop low-cost and accessible methods to identify individuals who may have the disease before they show clinical symptoms. By examining how people name animals in a one-minute task, the study looks for patterns in language that may reveal early cognitive decline. This approach seeks to provide a more sensitive measure of cognitive impairment that can be used across diverse populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults, particularly those who may be at risk for Alzheimer's disease but do not yet show clinical symptoms.
Not a fit: Patients who are already diagnosed with Alzheimer's disease or those with significant cognitive impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate diagnosis of Alzheimer's disease, allowing for timely interventions.
How similar studies have performed: Other research has shown promise in using cognitive and language measures for early detection of Alzheimer's, indicating that this approach is both relevant and potentially impactful.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Vonk, Jet M.j. — University of California, San Francisco
- Study coordinator: Vonk, Jet M.j.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.